Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Deborah Schofield is active.

Publication


Featured researches published by Deborah Schofield.


Nature Reviews Rheumatology | 2014

The individual and socioeconomic impact of osteoarthritis

David J. Hunter; Deborah Schofield; Emily J. Callander

Osteoarthritis (OA) is a highly prevalent, disabling disease, with a commensurate tremendous individual and socioeconomic burden. This Perspectives article focuses on the burden of OA for the individual, the health-care system and society, to draw attention to the magnitude of the current problem with some reference to projected figures. We have an urgent opportunity to make fundamental changes to the way we care for individuals with OA that will have an effect upon the direct and indirect costs of this disease. By focusing on the burden of this prevalent, disabling, and costly disease, we hope to highlight the opportunity for shifts in health-care policy towards prevention and chronic-disease management.


Human Resources for Health | 2012

Access to general practitioner services amongst underserved Australians: a microsimulation study

Deborah Schofield; Rupendra Shrestha; Emily J. Callander

BackgroundOne group often identified as having low socioeconomic status, those living in remote or rural areas, are often recognised as bearing an unequal burden of illness in society. This paper aims to examine equity of utilisation of general practitioner services in Australia.MethodsUsing the 2005 National Health Survey undertaken by the Australian Bureau of Statistics, a microsimulation model was developed to determine the distribution of GP services that would occur if all Australians had equal utilisation of health services relative to need.ResultsIt was estimated that those who are unemployed would experience a 19% increase in GP services. Persons residing in regional areas would receive about 5.7 million additional GP visits per year if they had the same access to care as Australians residing in major cities. This would be a 18% increase. There would be a 20% increase for inner regional residents and a 14% increase for residents of more remote regional areas. Overall there would be a 5% increase in GP visits nationally if those in regional areas had the same access to care as those in major cities.ConclusionParity is an insufficient goal and disadvantaged persons and underserved areas require greater access to health services than the well served metropolitan areas due to their greater poverty and poorer health status. Currently underserved Australians suffer a double disadvantage: poorer health and poorer access to health services.


Genetics in Medicine | 2017

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement

Zornitza Stark; Deborah Schofield; Khurshid Alam; William Wilson; Nessie Mupfeki; Ivan Macciocca; Rupendra Shrestha; Susan M. White; Clara Gaff

Purpose:To undertake the first prospective cost-effectiveness study of whole-exome sequencing (WES) as an early, routine clinical test for infants with suspected monogenic disorders.Methods:Cost data for diagnosis-related investigations and assessments were collected for a prospective, sequential clinical cohort of infants (N = 40) who underwent singleton WES in parallel to usual diagnostic care. We determined costs per patient, costs per diagnosis, and incremental costs per additional diagnosis for three alternative strategies for integrating WES into the diagnostic trajectory. We performed a sensitivity analysis to examine the robustness of estimates and bootstrapping (500 replications) to examine their distributions.Results:Standard care achieved an average cost per diagnosis of AU


JAMA Pediatrics | 2017

Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions

Tiong Yang Tan; Oliver James Dillon; Zornitza Stark; Deborah Schofield; Khurshid Alam; Rupendra Shrestha; Belinda Chong; Dean Phelan; Gemma R. Brett; Emma Creed; Anna Jarmolowicz; Patrick Yap; Maie Walsh; Lilian Downie; David J. Amor; Ravi Savarirayan; George McGillivray; Alison Yeung; Heidi Peters; Susan J. Robertson; Aaron J Robinson; Ivan Macciocca; Simon Sadedin; Katrina M. Bell; Alicia Oshlack; Peter Georgeson; Natalie P. Thorne; Clara Gaff; Susan M. White

27,050 (US


Health Policy | 2010

Health problems and retirement due to ill-health among Australian retirees aged 45-64 years

Sabrina Pit; Rupendra Shrestha; Deborah Schofield; Megan Passey

21,099) compared with AU


International Journal of Obesity | 2013

A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial

Nicholas R. Fuller; Stephen Colagiuri; Deborah Schofield; Ashley Olson; Rupendra Shrestha; Christina Holzapfel; S B Wolfenstetter; R Holle; Amy L Ahern; Hans Hauner; Susan A. Jebb; Ian D. Caterson

5,047 (US


The Australian journal of physiotherapy | 2007

The physiotherapy workforce is ageing, becoming more masculinised, and is working longer hours: a demographic study

Deborah Schofield; Susan Fletcher

3,937) for singleton WES. If WES had been performed after exhaustive standard investigation, then there would have been an incremental cost per additional diagnosis of AU


BMC Public Health | 2011

Economic impacts of illness in older workers: quantifying the impact of illness on income, tax revenue and government spending.

Deborah Schofield; Rupendra Shrestha; Richard Percival; Megan Passey; Simon Kelly; Emily J. Callander

8,112 (US


Health Sociology Review | 2012

Towards a holistic understanding of poverty: a new multidimensional measure of poverty for Australia

Emily J. Callander; Deborah Schofield; Rupendra Shrestha

6,327). Using WES to replace some investigations decreases this incremental cost to AU


BMC Public Health | 2013

The personal and national costs of lost labour force participation due to arthritis: an economic study

Deborah Schofield; Rupendra Shrestha; Richard Percival; Megan Passey; Emily J. Callander; Simon Kelly

2,622 (US

Collaboration


Dive into the Deborah Schofield's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Simon Kelly

University of Canberra

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge